Bank of New York Mellon Corp Buys New Shares in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Bank of New York Mellon purchased 559,436 shares of Acadia Healthcare, valued at approximately $16.5 million, representing about 0.60% of the company.
• Acadia reported quarterly EPS of $0.38, beating estimates of $0.35, while revenue reached $865.84 million. However, revenue declined 0.4% year over year and the company posted a negative net margin.
• ACHC shares opened at $27.56, down 3.5%, while analyst sentiment remained mixed: the consensus rating was “Hold” with an average price target of $29.85.

Bank of New York Mellon Corp purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 559,436 shares of the company's stock, valued at approximately $16,520,000. Bank of New York Mellon Corp owned approximately 0.60% of Acadia Healthcare at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in ACHC. EverSource Wealth Advisors LLC increased its stake in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company's stock worth $32,000 after buying an additional 497 shares during the period. Federated Hermes Inc. increased its position in shares of Acadia Healthcare by 1.5% in the 4th quarter. Federated Hermes Inc. now owns 43,913 shares of the company's stock valued at $623,000 after purchasing an additional 668 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of Acadia Healthcare by 0.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company's stock valued at $1,063,000 after purchasing an additional 696 shares in the last quarter. Public Employees Retirement System of Ohio lifted its position in shares of Acadia Healthcare by 2.8% during the 3rd quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company's stock worth $776,000 after purchasing an additional 867 shares during the last quarter. Finally, Treasurer of the State of North Carolina grew its stake in shares of Acadia Healthcare by 2.1% during the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company's stock worth $964,000 after purchasing an additional 867 shares in the last quarter.

Acadia Healthcare Stock Down 3.5%

ACHC stock opened at $27.56 on Tuesday. The company has a market cap of $2.57 billion, a price-to-earnings ratio of -2.21, a price-to-earnings-growth ratio of 9.20 and a beta of 0.64. The company has a fifty day moving average price of $30.51 and a 200 day moving average price of $26.25. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. Acadia Healthcare Company, Inc. has a 12 month low of $11.43 and a 12 month high of $35.83.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last announced its earnings results on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.03. Acadia Healthcare had a negative net margin of 33.44% and a positive return on equity of 6.19%. The business had revenue of $865.84 million during the quarter, compared to analysts' expectations of $844.19 million. During the same period in the prior year, the company earned $0.83 earnings per share. The business's revenue was down .4% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts expect that Acadia Healthcare Company, Inc. will post 1.55 earnings per share for the current year.

Analyst Ratings Changes

ACHC has been the topic of a number of analyst reports. TD Cowen raised their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Guggenheim increased their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the company a "buy" rating in a report on Thursday, July 30th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Acadia Healthcare in a report on Friday, June 12th. Cantor Fitzgerald reissued a "neutral" rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. Finally, KeyCorp lifted their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an "overweight" rating in a research note on Tuesday, July 14th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $29.85.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source